Clinical Trials Directory

Trials / Unknown

UnknownNCT05605873

Clinical, Histological and Prognostic Forms of Adenocarcinoma of the Anus

Status
Unknown
Phase
Study type
Observational
Enrollment
46 (estimated)
Sponsor
Fondation Hôpital Saint-Joseph · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Adenocarcinoma of the anus is rare. It concerns less than 10% of anal cancers and its incidence is less than 0.2/100 000 inhabitants. Its management is not consensual and is most often derived by analogy with that of adenocarcinoma of the lower rectum. This is due to the rarity but also to the diversity of anatomical (anal margin, anal canal, lower rectum), etiological (primary glandular tumors or secondary to anal fistula, primary distant tumor and/or Crohn's disease) and histological forms (mucinous, intestinal, glandular adenocarcinomas and primary or secondary Paget's disease). Most of the literature consists of small case series and simple clinical cases in which the prognosis of these subforms has not been studied.

Conditions

Timeline

Start date
2022-09-16
Primary completion
2022-10-16
Completion
2023-12-31
First posted
2022-11-04
Last updated
2022-11-10

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05605873. Inclusion in this directory is not an endorsement.

Clinical, Histological and Prognostic Forms of Adenocarcinoma of the Anus (NCT05605873) · Clinical Trials Directory